These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 8451007)

  • 1. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers.
    Pavlath GK; Rando TA; Blau HM
    J Cell Biol; 1994 Dec; 127(6 Pt 2):1923-32. PubMed ID: 7806570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HLA-DR expression on human myoblasts with interferon-gamma.
    Hohlfeld R; Engel AG
    Am J Pathol; 1990 Mar; 136(3):503-8. PubMed ID: 2107747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aberrant expression of major histocompatibility complex class II antigen in inflammatory myopathies].
    Kojima S; Takagi A
    Rinsho Shinkeigaku; 1993 Jun; 33(6):612-9. PubMed ID: 8403680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma.
    Mantegazza R; Hughes SM; Mitchell D; Travis M; Blau HM; Steinman L
    Neurology; 1991 Jul; 41(7):1128-32. PubMed ID: 1906147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of major histocompatibility complex antigen expression on cultured human embryonic skeletal myoblasts.
    Bao S; dos Remedios CG; King NJ
    Transplantation; 1994 Sep; 58(5):585-91. PubMed ID: 8091485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I and II expression in rhabdomyosarcomas.
    Fernández JE; Concha A; Aránega A; Ruiz-Cabello F; Cabrera T; Garrido F
    Immunobiology; 1991 Aug; 182(5):440-8. PubMed ID: 1916885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen recognition.
    Cresswell P; Howard JC
    Curr Opin Immunol; 1997 Feb; 9(1):71-4. PubMed ID: 9039787
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigen processing and presentation--towards the millennium.
    Hämmerling GJ; Vogt AB; Kropshofer H
    Immunol Rev; 1999 Dec; 172():5-9. PubMed ID: 10631932
    [No Abstract]   [Full Text] [Related]  

  • 9. N-CAM is a target cell surface antigen for the purification of muscle cells for myoblast transfer therapy.
    Walsh FS
    Adv Exp Med Biol; 1990; 280():41-5; discussion 46. PubMed ID: 2248154
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermediates in class II HLA antigen biosynthesis.
    Cresswell P; Kelner DN; Marks MS
    Adv Exp Med Biol; 1987; 225():37-42. PubMed ID: 3331063
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts.
    Hardiman O; Faustman D; Li X; Sklar RM; Brown RH
    Neurology; 1993 Mar; 43(3 Pt 1):604-8. PubMed ID: 8451007
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.